Heart failure with reduced ejection fraction

There are 458 papers on heart failure with reduced ejection fraction in aging research: 49 trials and 270 observational studies in people, 7 in animals, 2 in cells, 107 reviews. The newest story, Nov 17, 2026: “Fine-particle pollution linked to heart failure types in China”.

Disease

458 papers study it44 more mention it60 findings

138 new papers in 30 daysSee all 502 papers on heart failure with reduced ejection fraction

At a glance

Heart failure with reduced ejection fraction is linked with higher mortality in human studies and worse cognition in heart failure outpatients. It is associated with a higher heart proteomic age gap than preserved-ejection-fraction heart failure; estimated pulse wave velocity is linked with higher risk, whereas carotid-femoral pulse wave velocity shows no clear link after adjustment.

60 findings in 51 papers from 2015 to 2026, 11 of them since September 2026

“A significant risk reduction in total events was observed in the ILR group for the composite of HFrEF event or cardiovascular death and for HFrEF event (hazard ratio, 0.74 [95% CI, 0.56-0.98] and 0.65 [95% CI, 0.44-0.97], respectively).”
Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP StudyCirculation. Arrhythmia and electrophysiology2024doi:10.1161/circep.124.012764
  • Human trial49
  • Humans270
  • Animals7
  • Cells2
  • In silico6

Interventions

2

Ultra-processed foods

no changein humans1

1 study
  1. Ultra-processed foods were not clearly linked with heart failure with reduced ejection fraction in humans (without cardiovascular disease at baseline).

    “UPF intake remained significantly associated with HFpEF (HR 1.096; 95% CI 1.016–1.183), but not HFrEF.”

    Humanswithout cardiovascular disease at baseline

    Ultra-processed foods linked to heart failure in US adults

    JACC. Heart failure

More on Ultra-processed foods

High-fat diet

upin mice1

1 study
  1. High-fat diet induces heart failure with reduced ejection fraction in mice (diet-induced obesity).

    “Subsequently, aged mice with DIO developed overt heart failure with reduced ejection fraction, while cardiac function was unaffected by DIO in young mice.”

    Animalsdiet-induced obesityheart8 weeksmales

    Age-dependent impairment of cardiac function and physical performance in male mice with diet-induced obesity

    GeroScience

More on High-fat diet

Effects

7

Mortality

mediatesin humans1no changein humans1OR 1.417

2 studies
  1. Heart failure with reduced ejection fraction is linked with mortality in humans (indirect effect mediating sex-related difference in TR-associated mortality) (indirect OR 1.417).

    “heart failure with reduced ejection fraction (HFrEF; indirect OR 1.417).”

    Humansindirect effect mediating sex-related difference in TR-associated mortalityn = 122,501

    Sex, comorbidities, and mortality in tricuspid regurgitation: Reassessing risk beyond valve severity

    ESC Congress 2026 abstract

  2. Heart failure with reduced ejection fraction showed no clear effect on mortality in patients with sarcopenic heart failure (HR = 1.57, 95% CI: 0.66-3.77).

    “Prognostic comparisons between patients with sarcopenic HFrEF and HFpEF also showed no significant difference (hazard ratio = 1.57, 95% CI: 0.66-3.77; I 2 = 79%, p = 0.029).”

    Reviewin patients with sarcopenic heart failure

    Comparison of sarcopenia prevalence and prognostic features between HFrEF and HFpEF: a systematic review and meta-analysis

    Frontiers in cardiovascular medicine

Cognitive function

downin humans1

1 study
  1. Heart failure with reduced ejection fraction is linked with worse cognitive function in humans (heart failure outpatients) (aOR 6.10; 95% CI 1.25 to 29.87; p=0.03).

    “HFrEF was associated with worse cognition (aOR 6.10; 95% CI 1.25 to 29.87; p=0.03).”

    Humansheart failure outpatientsn = 107

    Polypharmacy and Potentially Inappropriate Medications: Cognitive Consequences in Older Heart Failure Outpatients

    Romanian journal of internal medicine = Revue roumaine de medecine interne

Sarcopenia

no changein humans1RR 1.12

1 study
  1. Heart failure with reduced ejection fraction showed no clear effect on sarcopenia in patients with heart failure (RR = 1.12, 95% CI: 1.01-1.23).

    “A meta-analysis of studies directly comparing HFrEF and HFpEF found no significant difference in sarcopenia prevalence (fixed-effect model: RR = 1.12, 95% CI: 1.01-1.23; I 2 = 23%, p = 0.273).”

    Reviewin patients with heart failure

    Comparison of sarcopenia prevalence and prognostic features between HFrEF and HFpEF: a systematic review and meta-analysis

    Frontiers in cardiovascular medicine

More on Sarcopenia

Ejection fraction

downin cynomolgus monkeys1

1 study
  1. Heart failure with reduced ejection fraction decreases ejection fraction in cynomolgus monkeys (53 ± 4.6% vs. 73 ± 4.3%).

    “HFrEF models showed markedly reduced ejection fraction (EF<60%; 53 ± 4.6% vs. 73 ± 4.3% controls).”

    Animalsheartmales

    Multimodal Imaging Characterization of Chronic Cardiac Pathologies in Aged Cynomolgus Monkeys: Translational Insights into Heart Failure and Amyloidosis

    AHA Scientific Sessions 2025 abstract

Cortical curvature

upin humans1

1 study
  1. Heart failure with reduced ejection fraction is linked with higher cortical curvature in humans (heart failure with reduced ejection fraction) (young: 0.127 ± 0.003, old: 0.128 ± 0.003, HFrEF: 0.136 ± 0.005 mm−1).

    “Whereas age had little effect on cortical curvature (P = 0.60), it was greater in HFrEF (young: 0.127 ± 0.003, old: 0.128 ± 0.003, HFrEF: 0.136 ± 0.005 mm−1, P < 0.01).”

    Humansheart failure with reduced ejection fraction

    Cardiac dysfunction is associated with indices of brain atrophy and cognitive impairment in heart failure with reduced ejection fraction

    Journal of applied physiology (Bethesda, Md. : 1985)

More on Cortical curvature

Cortical thickness

downin humans1

1 study
  1. Heart failure with reduced ejection fraction is linked with lower cortical thickness in humans (heart failure with reduced ejection fraction) (young: 2.44 ± 0.07, old: 2.33 ± 0.08, HFrEF: 2.22 ± 0.10 mm).

    “cortical thickness (young: 2.44 ± 0.07, old: 2.33 ± 0.08, HFrEF: 2.22 ± 0.10 mm, P < 0.01) were lower with age and lowered further with HFrEF.”

    Humansheart failure with reduced ejection fraction

    Cardiac dysfunction is associated with indices of brain atrophy and cognitive impairment in heart failure with reduced ejection fraction

    Journal of applied physiology (Bethesda, Md. : 1985)

More on Cortical thickness

Gray matter volume

downin humans1

1 study
  1. Heart failure with reduced ejection fraction is linked with lower gray matter volume in humans (heart failure with reduced ejection fraction) (young: 492 ± 24, old: 456 ± 24, HFrEF: 433 ± 32 cm3).

    “Gray matter volume (GMV) (young: 492 ± 24, old: 456 ± 24, HFrEF: 433 ± 32 cm3, P ≤ 0.05) and cortical thickness (young: 2.44 ± 0.07, old: 2.33 ± 0.08, HFrEF: 2.22 ± 0.10 mm, P < 0.01) were lower with age and lowered further with HFrEF.”

    Humansheart failure with reduced ejection fraction

    Cardiac dysfunction is associated with indices of brain atrophy and cognitive impairment in heart failure with reduced ejection fraction

    Journal of applied physiology (Bethesda, Md. : 1985)

More on Gray matter volume

Upstream

6

Hepcidin

no changein humans1HR 1.08

1 study
  1. Hepcidin was not clearly linked with heart failure with reduced ejection fraction in humans (free from prevalent anaemia and HF) (HR 1.08, 95% CI 0.94-1.24 per 50% lower hepcidin).

    “Plasma hepcidin level was not significantly associated with the risk of incident HFrEF [HR (95% CI): 1.08 (0.94-1.24); P = 0.30].”

    Humansfree from prevalent anaemia and HFplasma

    Hepcidin, incident heart failure, and cardiac dysfunction in older adults: the ARIC study

    European journal of preventive cardiology

More on Hepcidin

Ferritin

no changein humans1

1 study
  1. Ferritin was not clearly linked with heart failure with reduced ejection fraction in humans (older adults free of prevalent HF and anemia).

    “Associations with incident HFrEF were not statistically significant.”

    Humansolder adults free of prevalent HF and anemiaplasman = 3,472

    Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function: The ARIC Study

    JACC. Heart failure

More on Ferritin

SDNN

no changein humans1HR 1.19

1 study
  1. SDNN was not clearly linked with heart failure with reduced ejection fraction in humans (HR 1.19, 95% CI 0.95–1.50; lowest versus highest quartile).

    “but not with HFrEF (Q1 vs Q4 SDNN: 1.19, 95% CI 0.95, 1.50; Q1 RMSSD: 1.13, 95% CI 0.90, 1.43).”

    HumansPostmenopausal women free of baseline coronary heart disease and heart failure; lowest versus highest SDNN quartilefemalesn = 28,603

    Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women's Health Initiative study

    PloS one

More on SDNN

Frailty index

no changein humans1HR 1.19

1 study
  1. Frailty index was not clearly linked with heart failure with reduced ejection fraction in humans (type 2 diabetes mellitus without prevalent HF) (HR 1.19, 95% CI 0.96-1.46 per 1-SD higher FI).

    “but not HFrEF (HR [95% CI]: 1.19 [0.96-1.46]) after adjustment for potential confounders, including traditional HF risk factors.”

    Humanstype 2 diabetes mellitus without prevalent HFper 1-SD higher FIn = 5,100

    Association of Baseline and Longitudinal Changes in Frailty Burden and Risk of Heart Failure in Type 2 Diabetes-Findings from the Look AHEAD Trial

    The journals of gerontology. Series A, Biological sciences and medical sciences

More on Frailty index

Soluble CD14

no changein humans1HR 0.99

1 study
  1. Soluble CD14 was not clearly linked with heart failure with reduced ejection fraction in humans among participants with classifiable heart failure subtypes (HR 0.99 (95% CI 0.67-1.49)).

    “This association for sCD14 was observed with HFpEF (HR: 1.50, 95% CI: 1.07-2.10) but not HFrEF (HR: 0.99, 95% CI: 0.67-1.49).”

    Humansamong participants with classifiable heart failure subtypes13.6 yearsn = 419

    Soluble CD14 and Risk of Heart Failure and Its Subtypes in Older Adults

    Journal of cardiac failure

More on Soluble CD14

Carotid-femoral pulse wave velocity

no changein humans1HR 1.28

1 study
  1. Carotid-femoral pulse wave velocity was not clearly linked with heart failure with reduced ejection fraction in humans after adjustment for potential confounders (HR 1.28 (95% CI 0.83-1.97)).

    “most adjusted hazard ratio [95% confidence interval] for cf-PWV tertile 3 versus tertile 1 [ref]: HFpEF, 1.06 [0.72-1.56]; HFrEF, 1.28 [0.83-1.97]”

    Humansafter adjustment for potential confoundersn = 2,290

    Arterial Stiffness and Risk of Overall Heart Failure, Heart Failure With Preserved Ejection Fraction, and Heart Failure With Reduced Ejection Fraction: The Health ABC Study (Health, Aging, and Body Composition)

    Hypertension (Dallas, Tex. : 1979)

More on Carotid-femoral pulse wave velocity

Associations

39

Mortality

upin humans5HR 3.028–6.41

5 studies
  1. Heart failure with reduced ejection fraction is linked with a higher risk of mortality in humans (patients with HFrEF vs general population controls) (HR 6.41 (95% CI: 3.73-11.05) in aged 40-49 years).

    “HFrEF was associated with excess mortality across all age groups.”

    Humanspatients with HFrEF vs general population controls

    Effect of age on 5-year excess mortality in heart failure with reduced ejection fraction

    European journal of heart failure

  2. Heart failure with reduced ejection fraction is associated with mortality in humans with cardiac dual-chamber pacemaker implantation (HR=3.028, 95%CI 1.181-7.763, P=0.021).

    “heart failure with reduced ejection fraction (HR=3.028, 95%CI 1.181-7.763, P=0.021) were both independently associated with cardiovascular mortality.”

    Humanswith cardiac dual-chamber pacemaker implantationn = 169

    Impact of atrial high-rate episodes on new onset of atrial fibrillation and all-cause mortality in elderly patients over 90 years old with dual-chamber pacemaker implantation

    Zhonghua xin xue guan bing za zhi

  3. Heart failure with reduced ejection fraction is linked with a higher risk of mortality in patients with heart failure and sarcopenia (log-rank p = 0.002).

    “Kaplan-Meier analysis for all-cause death showed that the HFrEF group had a significantly worse prognosis than the HFpEF group [log-rank p = 0.002].”

    Humansin patients with heart failure and sarcopenia

    Prognostic factors in patients with heart failure and sarcopenia: an observational retrospective study

    The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

  4. Heart failure with reduced ejection fraction is linked with a higher risk of mortality in humans (critically ill COVID-19 patients with pre-existing heart failure) (64% vs. 48%, P = 0.042).

    “Crude 30 day mortality was significantly higher in HFrEF compared with HFpEF (64% vs. 48%, P = 0.042).”

    Humanscritically ill COVID-19 patients with pre-existing heart failure

    Association of chronic heart failure with mortality in old intensive care patients suffering from Covid-19

    ESC heart failure

  5. Heart failure with reduced ejection fraction is linked with a higher risk of mortality in humans (CKD) (adjusted HR 4.78, 95% CI 1.26-18.11).

    “4.78 (95% CI 1.26-18.11) for HFrEF”

    HumansCKDmean follow-up 3.1 ± 2.1 yearsn = 331

    Impacts of Heart Failure and Physical Performance on Long-Term Mortality in Old Patients With Chronic Kidney Disease

    Frontiers in cardiovascular medicine

NT-proBNP

upin humans2HR 2.07

2 studies
  1. NT-proBNP is associated with heart failure with reduced ejection fraction in humans (HR 2.07; 95% CI, 1.87 to 2.31).

    “with a stronger association for HFrEF than HFpEF (HRHFrEF, 2.07; 95% CI, 1.87 to 2.31 vs HRHFpEF, 1.48; 95% CI, 1.27 to 1.72; Pdifference<.001)”

    Humansplasma23.4 yearsn = 8,486

    Associations of Serially Measured NT-proBNP With Incident Heart Failure With Reduced and Preserved Ejection Fraction

    Mayo Clinic proceedings

  2. Heart failure with reduced ejection fraction is associated with NT-proBNP in humans.

    “NT-proBNP, BNP, hs-cTnT, renin, angiotensin-converting enzyme 2, growth differentiation factor 15, and interleukin-6 levels were higher in HF with reduced ejection fraction”

    Humansatrial fibrillation with prevalent heart failure; comparison with preserved ejection fractionplasma

    Plasma Biomarkers Associated With Heart Failure Hospitalization Among Patients With Atrial Fibrillation and Subtypes of Heart Failure

    Journal of the American Heart Association

More on NT-proBNP

Indoor radon

upin humans1HR 1.24

1 study
  1. Indoor radon is associated with heart failure with reduced ejection fraction in humans (US postmenopausal women) (HR 1.24, 95% CI 1.04–1.49).

    “The HR was higher for heart failure with reduced ejection fraction (1.24; 95% CI, 1.04-1.49)”

    HumansUS postmenopausal women>4 pCi/L versus <2 pCi/LMean follow-up of 16.2 yearsfemalesn = 43,188

    Indoor radon linked to heart failure in postmenopausal women

    JAMA network open

More on Indoor radon

Lipoprotein

upin humans1HR 1.33

1 study
  1. Lipoprotein is associated with heart failure with reduced ejection fraction in humans (White participants with lipoprotein(a) ≥50 mg/dL) (HR 1.33, 95% CI 1.05–1.67).

    “Among White participants with Lp(a) ≥50 mg/dL, risk was elevated for both HFpEF (HR 1.32; 1.08-1.59) and HFrEF (HR 1.33; 1.05-1.67)”

    ReviewWhite participants with lipoprotein(a) ≥50 mg/dL

    Lipoprotein(a) and Incident Heart Failure: A Meta-Analysis of Prospective Cohort Studies

    AHA Scientific Sessions 2026 abstract

More on Lipoprotein

Hypertensive crisis

upin humans1HR 2.64

1 study
  1. Hypertensive crisis is associated with heart failure with reduced ejection fraction in humans (11.039% vs 3.896%; HR 2.640 [1.962-3.550]).

    “Hypertensive crisis hospitalization was associated with higher observed 3-year risk of incident HFpEF, HFrEF, atrial fibrillation/flutter, and MACE.”

    HumansHospitalized adults with hypertension and no prior heart failure or atrial fibrillation/flutter; compared with hospitalized hypertensive controls without documented crisis3 years

    Hypertensive Crisis Hospitalization as a Marker of Future Heart Failure, Atrial Fibrillation, and Major Adverse Cardiovascular Events

    AHA Scientific Sessions 2026 abstract

More on Hypertensive crisis

Heart proteomic age gap

upin humans1

1 study
  1. Heart failure with reduced ejection fraction is associated with heart proteomic age gap in humans (HFrEF compared with HFpEF) (Estimate 0.72; p<10 −12).

    “HFrEF age gaps were accelerated compared to HFpEF for all models except lung, liver, immune and the conventional model, with the strongest differences observed for heart”

    HumansHFrEF compared with HFpEF

    Protein-based age measures differ by heart failure type

    AHA Scientific Sessions 2026 abstract

More on Heart proteomic age gap

Heart failure hospitalization rate

upin humans1

1 study
  1. Heart failure with reduced ejection fraction is associated with heart failure hospitalization rate in humans (CKD stages 4-5; comparison among heart failure types).

    “One-year mortality and 1-year rate of HF hospitalizations were significantly higher in patients with HFrEF and lower in those with HFpEF in cases of CKD 4-5”

    HumansCKD stages 4-5; comparison among heart failure types1 year

    Differences in outcomes according to the type of heart failure and kidney disease stages in patients with heart failure and chronic kidney disease

    ESC Congress 2026 abstract

1-year mortality

upin humans1

1 study
  1. Heart failure with reduced ejection fraction is associated with 1-year mortality in humans (CKD stages 4-5; comparison among heart failure types).

    “One-year mortality and 1-year rate of HF hospitalizations were significantly higher in patients with HFrEF and lower in those with HFpEF in cases of CKD 4-5”

    HumansCKD stages 4-5; comparison among heart failure types1 year

    Differences in outcomes according to the type of heart failure and kidney disease stages in patients with heart failure and chronic kidney disease

    ESC Congress 2026 abstract

Multi-variate time series transformer

upin silico1

1 study
  1. multi-variate time series transformer predicts heart failure with reduced ejection fraction in silico (AUROC 0.956, sensitivity 92.4%).

    “Cross-sectional HFrEF detection: the fine-tuned regression model achieved AUROC 0.956, with sensitivity 92.4% at the Youden-optimal threshold.”

    In silicon = 18,376

    ECG-based transformer model predicts future left ventricular ejection fraction deterioration: from cross-sectional screening to longitudinal risk stratification

    ESC Congress 2026 abstract

Guideline-directed medical therapy score

upin humans1

1 study
  1. Heart failure with reduced ejection fraction is associated with guideline-directed medical therapy score in humans (HFrEF compared with HFpEF) (1.72±1.22 vs. 1.12±0.92).

    “GDMT scores were greater in HFrEF (1.72±1.22 vs. 1.12±0.92, p<0.001).”

    HumansHFrEF compared with HFpEF46% malesn = 575

    Clinical Profiles and Guideline-Directed Therapy Patterns in Heart Failure With Preserved Versus Reduced Ejection Fraction: A Single-Center Retrospective Cohort Study From Pakistan

    International journal of heart failure

Progeria

upin humans1

1 study
  1. Progeria is associated with heart failure with reduced ejection fraction in humans (secondary to degenerative valvular heart disease).

    “Our patient presented with heart failure with reduced ejection fraction secondary to degenerative valvular heart disease.”

    Human trialsecondary to degenerative valvular heart diseasemales

    Redefining Aging: A Tale of Hutchinson-Gilford Progeria Syndrome

    The Journal of the Association of Physicians of India

More on Progeria

Implantable loop recorder

downin humans1

1 study
  1. Implantable loop recorder lowers the risk of heart failure with reduced ejection fraction in humans (hazard ratio, 0.65 [95% CI, 0.44-0.97]).

    “A significant risk reduction in total events was observed in the ILR group for the composite of HFrEF event or cardiovascular death and for HFrEF event (hazard ratio, 0.74 [95% CI, 0.56-0.98] and 0.65 [95% CI, 0.44-0.97], respectively).”

    Human trialn = 6,004

    Heart Failure Events After Long-term Continuous Screening for Atrial Fibrillation: Results From the Randomized LOOP Study

    Circulation. Arrhythmia and electrophysiology

More on Implantable loop recorder

All 39

Trial sponsors

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies link heart failure with reduced ejection fraction to higher mortality, worse cognition in heart failure outpatients, and a larger heart proteomic age gap than preserved-ejection-fraction heart failure. A cohort in type 2 diabetes without prior heart failure finds no clear frailty link. A human trial reports lower risk with an implantable loop recorder.

  2. Summary written from the findings.

Latest

Dec 2025: 11Jan 2026: 25Feb 2026: 27Mar 2026: 30Apr 2026: 6May 2026: 7Jun 2026: 5Jul 2026: 5Aug 2026: 7Sep 2026: 18Oct 2026: 77Nov 2026: 61279 papers in 12 months
Environmental Science & Technology

Fine-particle pollution linked to heart failure types in China

A prospective cohort followed 101,521 Chinese adults for a median 14.83 years, linking different pollution components to different heart failure subtypes.A prospective cohort followed 101,521 Chinese adults for a median 14.83 years, linking different pollution components to different heart failure subtypes.

Cohort · 101,521 peopleHeart failure

See all 502 papers on heart failure with reduced ejection fraction